NCT07411703Enrolling by invitation
Automated Trainer-Based Gait Rehabilitation for Hemiplegic Stroke Patients
Gait Training for Hemiplegic Stroke Patients: Employing an Automated Trainer With Sensory Cues
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of an automated mobile gait training device developed based on neurodevelopmental treatment (NDT) principles for patients with hemiplegic stroke. Stroke is a major cause of long-term disability, and many survivors experience impaired walking ability that affects their independence and daily functioning. NDT is a commonly used rehabilitation approach that emphasizes therapist-guided facilitation of normal movement patterns during gait training. However, conventional NDT gait training is physically demanding and time-consuming for therapists, which may limit the amount of repetitive gait practice patients can receive. To address these limitations, this study introduces a power-assisted gait training device capable of reproducing key therapeutic interventions typically provided by therapists. The system uses synchronized dynamic assistance, auditory cues, and wearable inertial measurement units (IMUs) to support gait training on the ground and facilitate more natural and repetitive walking practice. The IMUs provide objective gait data that are used to evaluate changes in swing-phase symmetry, pelvic rotation amplitude, and walking speed. The primary goal of this study is to assess changes in these gait parameters following training with the proposed NDT-based assistive device. The study plans to enroll 60 adult stroke survivors (aged 20 and older) over a 3-year period starting from March 26, 2025.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 9 Feb 2026
- Start date
- Mar 2025
- Primary completion date
- Mar 2028
- Lead sponsor
- Cheng-Hsin General Hospital
- Diseases
- Stroke
- NCT number
- NCT07411703
What you commit to
- Study type: Observational
- Planned participants: 60
- From Mar 2025 to the primary completion date, Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe impairment in vision, hearing, or cognition, making them unable to comply with assessments.
Other
- Presence of severe spinal cord injury or peripheral neuropathy.
- Unstable gait requiring assistive devices, or participants at high risk of falling.
- Lower limb fracture within the past 6 months.
Who the study is looking for
- Age ≥ 20 years, first-ever stroke, with Brunnstrom stage III to IV of the affected lower limb motor recovery.
- Functional Ambulation Category (FAC) level IV.
- Ability to ambulate on level ground without assistive devices.
- Ability to understand instructions and cooperate with assessments.
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cheng Hsin General Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.